Deutsch Barry M. 4
4 · XERIS PHARMACEUTICALS INC · Filed Mar 2, 2020
Insider Transaction Report
Form 4
Deutsch Barry M.
Chief Financial Officer
Transactions
- Award
Common Stock
2020-01-31+50,000→ 89,359 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These restricted stock units vest in three substantially equal annual installments beginning on January 31, 2021.